GSK earnings
This article was originally published in The Tan Sheet
Executive Summary
Consumer Healthcare sales grew 2% in 2005 to reach $5.46 bil. for the year, GlaxoSmithKline announces Feb. 8. OTC drug sales were up 1% to $2.4 bil. (£ = $1.74), with growth in analgesics up 5% and respiratory tract drugs up 6%. The consumer division's September sale of five U.S. prescription dermatologicals contributed to a 12% drop in sales for the unit. The firm is "absolutely confident" that its Consumer division can continue to increase operating margins, CEO J.P. Garnier stated during an earnings call. The comment was a response to a question about whether the division's operating margins, which have increased from 20% to 24% in recent years, are sustainable. "I think what's going to affect margin is the overall revenue growth of the consumer business in '06," Garnier stated. "But we do have a number of programs where actually we convert cost saving from manufacturing and SG&A into more promotion because promotion drives the sales line in this business." The firm is awaiting an FDA decision on the proposed OTC sale of Alli (orlistat 60 mg)...
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.